These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
504 related items for PubMed ID: 7723282
1. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers. D'Agnano I, D'Angelo C, Savarese A, Carlini M, Garofalo A, Bottari L, Santoro E, Giannarelli D, Vecchione A, Zupi G. Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282 [Abstract] [Full Text] [Related]
2. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis. Santoro E, Carboni M, Catarci M, Carlini M, Carboni F, Zupi G, Vecchione A, D'Agnano I, Giannarelli D, Santoro R, Garofalo A. Hepatogastroenterology; 1997 Apr; 44(15):826-37. PubMed ID: 9222700 [Abstract] [Full Text] [Related]
3. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, Androulakis GA. J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009 [Abstract] [Full Text] [Related]
10. Gastric cancer cell DNA content correlates with early and late results after gastrectomy. Carlini M, Garofalo A, Rinaldi G, D'Agnano I, D'Angelo C, Zupi G, Vecchione A, Santoro E. Int Surg; 1994 Apr; 79(2):114-9. PubMed ID: 7928145 [Abstract] [Full Text] [Related]
11. Mutated p53 protein expression and proliferative activity in advanced gastric cancer. Ikeguchi M, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N. Hepatogastroenterology; 1999 Apr; 46(28):2648-53. PubMed ID: 10522058 [Abstract] [Full Text] [Related]
13. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis. Esteban F, de Vega DS, Garcia R, Rodriguez R, Manzanares J, Almeida A, Tamames S. Hepatogastroenterology; 1999 Apr; 46(27):2039-43. PubMed ID: 10430394 [Abstract] [Full Text] [Related]
14. DNA ploidy is a major prognostic factor in advanced gastric carcinoma--univariate and multivariate analysis. Haraguchi M, Watanabe A, Moriguchi S, Korenaga D, Maehara Y, Okamura T, Sugimachi K. Surgery; 1991 Nov; 110(5):814-9. PubMed ID: 1948649 [Abstract] [Full Text] [Related]
15. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome. Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO. Cancer; 2007 May 15; 109(10):2016-24. PubMed ID: 17394193 [Abstract] [Full Text] [Related]
19. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G, Lindholm K, Falkmer U, Abrahamsson PA. Urology; 1997 Sep 15; 50(3):379-84. PubMed ID: 9301701 [Abstract] [Full Text] [Related]
20. Relationship of the epidermal growth factor-receptor to the growth fraction (Ki-67 antibody) and the flow cytometric S-phase as cell kinetics parameters, in human mammary carcinomas. Gasparini G, Reitano M, Bevilacqua P, Meli S, Pozza F, Santini G. Anticancer Res; 1991 Sep 15; 11(4):1597-603. PubMed ID: 1746917 [Abstract] [Full Text] [Related] Page: [Next] [New Search]